Search

The Cooper Companies, Inc. (https://www.barchart.com/stocks/quotes/CMS/overview), headquartered in San Ramon, California, is a global leader in medical devices and specialty healthcare products. With a https://www.barchart.com/stocks/quotes/CMS/profile, Cooper Companies focuses on delivering innovative [...]

Morgan Stanley raised the firm's price target on Cooper Companies to $104 from $95 and keeps an Equal Weight rating on the shares. The firm is updating its model for [...]

Notable gainers among liquid option names this morning include Best Buy (BBY) $98.62 +10.83, Cooper Companies (COO) $104.08 +9.53, CrowdStrike Holdings (CRWD) $282.08 +17.88, West Pharmaceutical (WST) $310.32 +12.71, and [...]

Baird raised the firm's price target on Cooper Companies to $125 from $118 and keeps an Outperform rating on the shares. The firm said they delivered solid FQ3 results, including [...]

Piper Sandler raised the firm's price target on Cooper Companies to $120 from $115 and keeps an Overweight rating on the shares after the company reported Q3 results. As previewed, [...]

Wells Fargo raised the firm's price target on Cooper Companies to $115 from $110 and keeps an Overweight rating on the shares. The firm notes the company reported Q3 sales/EPS [...]

Prior guidance was $3.54-$3.60. Raises FY24 revenue view to $3.89B-$3.91B from $3.86B-$3.91B, consensus [...]

Sees FY24 revenue $$3.89B- $3,91 , consensus [...]

Sees Q4 revenue $$1.015B-$1.036B , consensus $1.01B [...]

Reports Q revenue $1B, consensus $997.3M.Commenting on the results, Al White, Cooper's President and CEO said, 'Our strong performance this quarter reflects the strength of our business, the successful execution [...]

Jefferies upgraded Cooper Companies (COO) to Buy from Hold with a price target of $115, up from $107. The analyst views Cooper as best-positioned to take share in contact lens [...]

Consensus $3.54. Raises FY24 revenue view to $3.86B-$3.91B from $3.85B-$3.9B, consensus $3.88B. The company said, 'Non-GAAP diluted earnings per share guidance excludes amortization and impairment of intangible assets, and other [...]

Notable gainers among liquid option names this morning include Insulet (PODD) $171.70 +10.68, Illumina (ILMN) $119.53 +6.76, Enphase Energy (ENPH) $117.22 +6.44, Cooper Companies (COO) $96.33 +3.50, and Tesla (TSLA) [...]

Citi raised the firm's price target on Cooper Companies to $116 from $108 and keeps a Buy rating on the shares as part of a Q1 earnings preview for the [...]

Redburn Atlantic upgraded Cooper Companies to Buy from Neutral with a $125 price target. Cooper is set for continued share gains in a 'healthy' contact lens market, says the analyst, [...]

BofA initiated coverage of Cooper Companies with a Buy rating and $380 price target. The second-largest contact lens manufacturer with 26% share is better positioned than its three main competitors [...]

Mizuho lowered the firm's price target on Cooper Companies to $390 from $440 and keeps a Buy rating on the shares. The analyst lower targets on several medical technology names [...]

Redburn Atlantic analyst Issie Kirby downgraded Cooper Companies to Neutral from Buy with a price target of $343, down from $390. As the company undergoes a period of elevated investment, [...]

Citi lowered the firm's price target on Cooper Companies to $420 from $440 and keeps a Buy rating on the shares. In a note previewing the Q3 earnings reports, the [...]

Cooper Companies announced that it will transfer the listing of its common stock from the New York Stock Exchange to the Nasdaq Stock Market. Cooper expects to begin trading as [...]

Cooper Companies announced that it will transfer the listing of its common stock from the New York Stock Exchange to Nasdaq. Cooper expects to begin trading as a Nasdaq-listed company [...]

Cooper Companies, Inc. has filed a Form 144 with the U.S. Securities and Exchange Commission (SEC) on September 19, 2024. The company's SIC code is 3851, which pertains to Ophthalmic Goods. The filing indicates the proposed sale of restricted securities or securities held by an affiliate of the issuer, in accordance with Rule 144. This SEC filing is a formal document or financial statement submitted by publicly-traded companies. For more information, the SEC filing can be accessed at the provided link. [Extracted from the article]

Mizuho analyst Anthony Petrone raised the firm's price target on Cooper Companies to $440 from $400 and keeps a Buy rating on the shares. The analyst updated medtech and diagnostics [...]

Citi raised the firm's price target on Cooper Companies to $440 from $431 and keeps a Buy rating on the shares. The upcoming Q2 may be the most 'normal' quarter [...]

Baird analyst Jeff Johnson raised the firm's price target on Cooper Companies to $400 from $385 and keeps an Outperform rating on the shares. The firm said growth beat our [...]

Sees FY23 revenue $3.51B-$3.57B, consensus [...]

Reports Q3 revenue $877.4M, consensus $$865.14M. Commenting on the results, Al White, Cooper's President and CEO said, 'This was another strong quarter with CooperVision posting its ninth consecutive quarter of [...]